NA
OFIX icon

NewEdge Advisors’s Orthofix Medical OFIX Stock Holding History

NewEdge Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,014
Closed -$16.5K – 4108
2025
Q1 		$16.5K Hold
1,014
– – ﹤0.01% 2931
2024
Q4 		$17.7K Sell
1,014
-4,638
-82% -$80.6K ﹤0.01% 2840
2024
Q3 		$88.3K Hold
5,652
– – ﹤0.01% 2235
2024
Q2 		$74.9K Hold
5,652
– – ﹤0.01% 2202
2024
Q1 		$82.1K Hold
5,652
– – ﹤0.01% 2131
2023
Q4 		$76.2K Buy
5,652
+2,703
+92% +$31.8K ﹤0.01% 2061
2023
Q3 		$37.9K Hold
2,949
– – ﹤0.01% 2181
2023
Q2 		$53.3K Hold
2,949
– – ﹤0.01% 2066
2023
Q1 		$49.4K Hold
2,949
– – ﹤0.01% 2005
2022
Q4 		$61 Buy
+2,949
New +$52K ﹤0.01% 3441

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
AYAL Capital Advisors Toronto, Ontario, Canada $370M AUM 52.93% 1-Year Est. Return

NewEdge Advisors's OFIX Position: Q2 2025 in Review

NewEdge Advisors sold out of Orthofix Medical (OFIX) in Q2 2025, closing a stake of 1,014 shares — an estimated $16.5K sold.

NewEdge Advisors first reported a position in OFIX in Q4 2022 and held it in 10 quarters. The position peaked at $88.3K in Q3 2024. 158 funds tracked by Wall St. Rank hold OFIX as of Q2 2025.

  • NewEdge Advisors reported no remaining Orthofix Medical position as of Q2 2025 after selling out during the quarter.
  • NewEdge Advisors sold 1,014 Orthofix Medical shares in Q2 2025, an estimated $16.5K.
  • NewEdge Advisors first reported a position in Orthofix Medical in Q4 2022 and held it in 10 quarters.
  • NewEdge Advisors's Orthofix Medical position peaked at $88.3K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.